1. Kopple J.D.. National Kidney Foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure.
Am J Kidney Dis 37(Suppl 2):2001;S66–S70.
2. Kopple J.D.; National Kidney Foundation K/DOQI Work Group. The National Kidney Foundation K/DOQI clinical practice guidelines for dietary protein intake for chronic dialysis patients.
Am J Kidney Dis 38(Suppl 1):2001;S68–S73.
3. Blumenkrantz M.J., Gahl G.M., Kopple J.D., Kamdar A.V., Jones M.R., Kessel M., Coburn J.W.. Protein losses during peritoneal dialysis.
Kidney Int 19:1981;593–602.
4. Bossola M., Muscaritoli M., Valenza V., Panocchia N., Tazza L., Cascino A., Laviano A., Liberatori M., Lodovica Moussier M., Rossi Fanelli F., Luciani G.. Anorexia and serum leptin levels in hemodialysis patients.
Nephron Clin Pract 97:2004;c76–c82.
5. Chertow G.M., Ackert K., Lew N.L., Lazarus J.M., Lowrie E.G.. Prealbumin is as important as albumin in the nutritional assessment of hemodialysis patients.
Kidney Int 58:2000;2512–2517.
6. Kopple J.D.. Effect of nutrition on morbidity and mortality in maintenance dialysis patients.
Am J Kidney Dis 24:1994;1002–1009.
7. Avram M.M., Sreedhara R., Fein P., Oo K.K., Chattopadhyay J., Mittman N.. Survival on hemodialysis and peritoneal dialysis over 12 years with emphasis on nutritional parameters.
Am J Kidney Dis 37(Suppl 2):2001;S77–S80.
8. Avram M.M., Goldwasser P., Erroa M., Fein P.A.. Predictors of survival in continuous ambulatory peritoneal dialysis patients: the importance of prealbumin and other nutritional and metabolic markers.
Am J Kidney Dis 23:1994;91–98.
9. Ingenbleek Y., Young V.. Transthyretin (prealbumin) in health and disease: nutritional implications.
Annu Rev Nutr 14:1994;495–533.
10. Edefonti A., Picca M., Damiani B., Loi S., Ghio L., Giani M., Consalvo G., Grassi M.R.. Dietary prescription based on estimated nitrogen balance during peritoneal dialysis.
Pediatr Nephrol 13:1999;253–258.
11. Jacob V., Marchant P.R., Wild G., Brown C.B., Moorhead P.J., el Nahas A.M.. Nutritional profile of continuous ambulatory peritoneal dialysis patients.
Nephron 71:1995;16–22.
12. Mittman N., Avram M.M., Oo K.K., Chattopadhyay J.. Serum prealbumin predicts survival in hemodialysis and peritoneal dialysis: 10 years of prospective observation.
Am J Kidney Dis 38:2001;1358–1364.
13. Chertow G.M., Goldstein-Fuchs D.J., Lazarus J.M., Kaysen G.A.. Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients.
Kidney Int 68:2005;2794–2800.
14. Sreedhara R., Avram M.M., Blanco M., Batish R., Avram M.M., Mittman N.. Prealbumin is the best nutritional predictor of survival in hemodialysis and peritoneal dialysis.
Am J Kidney Dis 28:1996;937–942.
15. Keshaviah P.R., Nolph K.D., Moore H.L., Prowant B., Emerson P.F., Meyer M., Twardowski Z.J., Khanna R., Ponferrada L., Collins A.. Lean body mass estimation by creatinine kinetics.
J Am Soc Nephrol 4:1994;1475–1485.
16. Rambod M., Kovesdy C.P., Bross R., Kopple J.D., Kalantar-Zadeh K.. Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis.
Am J Clin Nutr 88:2008;1485–1494.
17. DeLong E.R., DeLong D.M., Clarke-Pearson D.L.. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.
Biometrics 44:1988;837–845.
18. Henze A., Espe K.M., Wanner C., Krane V., Raila J., Hocher B., Schweigert F.J., Drechsler C.. Transthyretin predicts cardiovascular outcome in hemodialysis patients with type 2 diabetes.
Diabetes Care 35:2012;2365–2372.
19. Noori N., Kovesdy C.P., Dukkipati R., Feroze U., Molnar M.Z., Bross R., Nissenson A.R., Kopple J.D., Norris K.C., Kalantar-Zadeh K.. Racial and ethnic differences in mortality of hemodialysis patients: role of dietary and nutritional status and inflammation.
Am J Nephrol 33:2011;157–167.
20. Cano N.J.. Metabolism and clinical interest of serum transthyretin (prealbumin) in dialysis patients.
Clin Chem Lab Med 40:2002;1313–1319.
21. Fouque D., Kalantar-Zadeh K., Kopple J., Cano N., Chauveau P., Cuppari L., Franch H., Guarnieri G., Ikizler T.A., Kaysen G., Lindholm B., Massy Z., Mitch W., Pineda E., Stenvinkel P., Treviño-Becerra A., Wanner C.. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease.
Kidney Int 73:2008;391–398.
22. Spiekerman A.M.. Proteins used in nutritional assessment.
Clin Lab Med 13:1993;353–369.
23. Fein P.A., Mittman N., Gadh R., Chattopadhyay J., Blaustein D., Mushnick R., Avram M.M.. Malnutrition and inflammation in peritoneal dialysis patients.
Kidney Int Suppl 64(Suppl 87):2003;S87–S91.
24. Noh H., Lee S.W., Kang S.W., Shin S.K., Choi K.H., Lee H.Y., Han D.S.. Serum C-reactive protein: a predictor of mortality in continuous ambulatory peritoneal dialysis patients.
Perit Dial Int 18:1998;387–394.
25. Devoto G., Gallo F., Marchello C., Racchi O., Garbarini R., Bonassi S., Albalustri G., Haupt E.. Prealbumin serum concentrations as a useful tool in the assessment of malnutrition in hospitalized patients.
Clin Chem 52:2006;2281–2285.
26. Blumenkrantz M.J., Kopple J.D., Gutman R.A., Chan Y.K., Barbour G.L., Roberts C., Shen F.H., Gandhi V.C., Tucker C.T., Curtis F.K., Coburn J.W.. Methods for assessing nutritional status of patients with renal failure.
Am J Clin Nutr 33:1980;1567–1585.
27. Cano N., Di Costanzo-Dufetel J., Calaf R., Durbec J.P., Lacombe P., Pascal S., Stroumza P., Labastle-Coeyrehourcq J.. Prealbumin-retinol-binding-protein-retinol complex in hemodialysis patients.
Am J Clin Nutr 47:1988;664–667.
28. Goldwasser P., Michel M.A., Collier J., Mittman N., Fein P.A., Gusik S.A., Avram M.M.. Prealbumin and lipoprotein(a) in hemodialysis: relationships with patient and vascular access survival.
Am J Kidney Dis 22:1993;215–225.
29. Avram M., Fein P., Rafiq M., Schloth T., Chattopadhyay J., Mittman N.. Malnutrition and inflammation as predictors of mortality in peritoneal dialysis patients.
Kidney Int 70:2006;S4–S7.
30. Lowrie E.G., Lew N.L.. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities.
Am J Kidney Dis 15:1990;458–482.
31. Port F.K.. Role of observational studies versus clinical trials in ESRD research.
Kidney Int 57(Suppl 74):2000;S3–S6.